Nuvo Group announced a partnership with Charité – Universitätsmedizin Berlin. The partnership, which has two main objectives, brings the previously established benefits of remote pregnancy monitoring to Europe for the first time, while also setting the stage for the use of predictive analytics to improve health outcomes in the future. The primary objective of the partnership seeks to define a remote pregnancy care protocol for Germany, and ultimately, all of Europe, allowing expectant mothers to conduct remote fetal surveillance from the comfort of their homes while still under the supervision of a physician.

In addition, the trial aims to identify predictive pathways for preeclamptic patients by extracting raw data from the INVU™ platform. Hypertension, the key indicator of preeclampsia, occurs in up to 10% of pregnancies. By pioneering a method to identify biomarkers for preeclampsia in its earliest stages, this partnership has a unique potential to improve outcomes for even the most at-risk patients.